As part of ancillary investigations from BETA to evaluate novel mechanisms relating exercise to breast cancer risk, we investigated whether a higher versus a more moderate volume of exercise would lead to differential changes in VEGF and FGF2 levels. The gene discussed is VEGFA; the disease is breast carcinoma.